Novartis copy of Amgen biotech drug shows similar efficacy-study
December 08, 2014 at 03:53 AM EST
ZURICH, Dec 8 (Reuters) - Novartis said its copycat version of Amgen's Neupogen for patients with low white blood cell counts works as well as the original drug in a late-stage trial.
